Denmark sets price ceiling for hospital meds

Denmark has introduced a three-year agreement to regulate price ceilings for hospital medicines, aimed at providing stability for the public healthcare system and pharmaceutical companies.

The deal, reached between the Ministry of the Interior and Health, Danish Regions, and industry body Lif, will reduce price ceilings by 5% over the period. Prices will decrease in three stages: by 2.1% on July 1, 2025, another 2.1% on February 1, 2026, and 0.8% on February 1, 2027.

Lif chief executive Ida Sofie Jensen highlighted the benefits of the deal, noting it would create “greater stability in price trends for hospital medicines, while also establishing stable framework conditions for the industry.”